Gilead stock ticks higher as earnings beat Street, revenue doesn't

Gilead stock ticks higher as earnings beat Street, revenue doesn't

Source: 
Marketwatch
snippet: 

Gilead Sciences Inc. GILD, +0.66% shares ticked higher in the extended session Thursday after the biotech drug maker topped Wall Street estimates for earnings but not for revenue.